How OpenAI's Search for Profits Led to Kevin Weil and a Strategic Reckoning

OpenAI stands at a crossroads. After Sam Altman publicly dismissed advertising as a business model just two years ago, the company is now integrating ads into ChatGPT. The shift reveals a deeper crisis: OpenAI must find new revenue streams or face an unsustainable financial future. Chief Science Officer Kevin Weil has become central to this transformation, helping shape a company-wide strategy that extends far beyond traditional ads.

The numbers tell a stark story. OpenAI earned approximately $13 billion in revenue last year, but faces a staggering $100 billion investment requirement over the next four years. This gap is driving the company toward multiple revenue initiatives simultaneously—an ambitious but risky approach that Kevin Weil and other new executives must now navigate.

The Financial Tightrope: Why OpenAI Can’t Rely on Current Models

While ChatGPT boasts 800 million users, only about 6% pay for subscriptions at $20 or more monthly. Consumer revenue currently accounts for 60% of OpenAI’s income, with enterprise products contributing 40%. For the company to break even and eventually go public, it needs to drastically accelerate growth. According to UBS analyst Karl Keirstead, “This is the key issue that tech investors care about today. OpenAI has no choice but to push more aggressively into the enterprise software market.”

The fundraising landscape has also tightened. Globally, few investors possess both the capital and willingness to commit additional billions for computational infrastructure. Wall Street remains an option, but executives privately acknowledge the company must achieve profitability first.

From Principles to Action: The Advertising Strategy

Two years ago, Altman declared that advertising would be OpenAI’s “last resort” as a business model, warning it would erode user trust. Today, that stance has reversed. The company now views advertising as necessary revenue generation, particularly from ChatGPT’s free tier users who represent the vast majority.

Building an advertising business from scratch poses enormous challenges. OpenAI lacks the organizational infrastructure, sales expertise, and technical systems that established players like Google have refined over decades. Mark Zagorski, CEO of advertising verification firm DoubleVerify, noted the gap: “OpenAI doesn’t really have a true sales team. They need to build the infrastructure and technical systems required to operate an ad business.”

The company has begun assembling an advertising division, but progress remains early-stage. In May of 2025, Altman recruited Fidji Simo, who previously led Instacart’s transformation into an advertising-centric business, as CEO of OpenAI’s applications division. Following her arrival, OpenAI aggressively hired hundreds of employees from Meta and X, many with advertising product experience.

The Enterprise Market: A Crowded Battlefield

While pursuing consumer advertising, OpenAI simultaneously aims to double enterprise revenue to 50% of total income by year-end. This strategy directly challenges entrenched competitors. Google has served businesses for decades, as has Microsoft. Tools like Codex help developers write code, and ChatGPT Enterprise attracts users paying up to $200 monthly. But competition is intensifying, particularly from Anthropic, whose ClaudeCode tool has gained traction in the AI programming segment.

Anthropic has openly mocked OpenAI’s advertising move, even airing a Super Bowl advertisement declaring: “The age of AI ads has arrived—but Claude has no ads.” Altman responded on X with a competitive jab: “Anthropic sells expensive products to rich people. We’re glad they do that; we do it too, but we also strongly believe we need to bring AI to the billions who can’t afford a subscription.”

Kevin Weil’s Value-Sharing Model: Ambition and Controversy

Beyond ads and enterprise tools, OpenAI introduced a more controversial revenue approach. During last year’s World Economic Forum in Davos, CFO Sarah Friar discussed what she called “value sharing”—the idea that if OpenAI’s technology contributes to scientific breakthroughs, the company might share in resulting profits. The remarks sparked immediate backlash from the research community.

Days later, OpenAI launched Prism, a product aimed at scientists. Many researchers interpreted Friar’s comments as signaling that OpenAI would claim stakes in their discoveries. The controversy threatened to alienate a key user demographic. Kevin Weil, newly appointed as Chief Science Officer, became instrumental in addressing the crisis. In a carefully worded social media post, Weil clarified that OpenAI would not extract cuts from individual scientists using Prism. However, he pointedly did not rule out partnerships with large pharmaceutical companies where OpenAI might share in profits.

Recently at a Silicon Valley event, Altman echoed this nuance: “We may explore some partnership models where we bear the costs and share in the proceeds.” Kevin Weil’s role as Chief Science Officer positions him to define the boundaries of these arrangements—critical work in maintaining both scientific credibility and profit potential.

The Organizational Overhaul: Too Much, Too Fast?

Industry observers question whether OpenAI can execute this multi-front strategy. Brian O’Kelley, CEO of internet advertising firm Scope3 with 20 years of experience, expressed skepticism: “OpenAI is trying to win over consumers, catch up with Anthropic’s programming tools, build data centers, and keep fundraising all at once. There’s just too much it’s chasing. Can it really do advertising well? Can it really do everything it wants to do well?”

Netflix took two years to build a viable advertising business, largely by outsourcing the work initially. OpenAI has compressed this timeline and chosen to build capabilities internally—a gamble that requires flawless execution across multiple business lines.

The Path Forward: Kevin Weil and Strategic Clarity

Kevin Weil’s appointment signals OpenAI’s recognition that its science officer must do more than manage technical research. He must navigate the tension between innovation ethics and commercial imperatives. His handling of the value-sharing controversy demonstrated this duality: protecting the scientific community while leaving the door open for lucrative pharma partnerships.

As OpenAI pursues advertising, enterprise expansion, and controversial new revenue models, Kevin Weil and other recently hired executives face pressure to deliver results quickly. The company’s survival depends on tripling revenue while managing competitors like Anthropic, skeptical investors, and an increasingly wary scientific community. Whether this complex balancing act succeeds remains an open question—but one that Kevin Weil now sits at the center of.